CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
---|---|---|---|---|---|---|
C00604 | BRD-A23980907 | BRD-A23980907 | -- | -- | -- | Details |
C00605 | BRD-A24021119 | BRD-A24021119 | -- | -- | -- | Details |
C00606 | BRD-A24054354 | BRD-A24054354 | -- | -- | -- | Details |
C00607 | BRD-A24122750 | saclofen | -- | -- | -- | Details |
C00608 | BRD-A24186493 | norethynodrel | -- | -- | -- | Details |
C00609 | BRD-A24191444 | ifenprodil | GRIN1; GRIN2B | Glutamate receptor antagonist; Adrenergic receptor antagonist | -- | Details |
C00610 | BRD-A24223049 | BRD-A24223049 | -- | -- | -- | Details |
C00611 | BRD-A24225650 | BRD-A24225650 | -- | -- | -- | Details |
C00612 | BRD-A24228527 | ofloxacin | -- | -- | -- | Details |
C00613 | BRD-A24284985 | anabasine | -- | -- | -- | Details |
C00614 | BRD-A24369193 | BRD-A24369193 | -- | -- | -- | Details |
C00615 | BRD-A24381660 | zeranol | -- | -- | -- | Details |
C00616 | BRD-A24396574 | celastrol | -- | -- | -- | Details |
C00617 | BRD-A24397426 | nadifloxacin | -- | -- | -- | Details |
C00618 | BRD-A24421185 | butylscopolammonium | -- | -- | -- | Details |
C00619 | BRD-A24429032 | BE-2254 | ADRA1A | Adrenergic receptor antagonist | -- | Details |
C00620 | BRD-A24436948 | BRD-A24436948 | -- | -- | -- | Details |
C00621 | BRD-A24514565 | warfarin | VKORC1 | Vitamin K antagonist | -- | Details |
C00622 | BRD-A24524033 | BRD-A24524033 | -- | -- | -- | Details |
C00623 | BRD-A24543851 | nornicotine | -- | -- | -- | Details |
C00624 | BRD-A24560335 | efatutazone | PPARG | PPAR receptor agonist | -- | Details |
C00625 | BRD-A24587114 | isoetharine | -- | -- | -- | Details |
C00626 | BRD-A24643465 | BRD-A24643465 | -- | -- | homoharringtonine | Details |
C00627 | BRD-A24714998 | BRD-A24714998 | -- | -- | -- | Details |
C00628 | BRD-A24817035 | laudanosine | -- | -- | -- | Details |
C00629 | BRD-A24891640 | nimodipine | NR3C2; CACNA1C; CACNA1D; CACNA1F; CACNA1S | Calcium channel blocker | -- | Details |
C00630 | BRD-A24951056 | BRD-A24951056 | -- | -- | -- | Details |
C00631 | BRD-A25004090 | erastin | VDAC2 | Ion channel antagonist | -- | Details |
C00632 | BRD-A25037258 | RTI-55 | -- | -- | -- | Details |
C00633 | BRD-A25067867 | benzatropine | CHRM1 | Acetylcholine receptor antagonist | -- | Details |
C00634 | BRD-A25088322 | CVF-SUMO-7 | -- | -- | -- | Details |
C00635 | BRD-A25143711 | hydrocortisone-valerate | NR3C1 | Corticosteroid agonist; Glucocorticoid receptor agonist | -- | Details |
C00636 | BRD-A25170757 | BRD-A25170757 | -- | -- | -- | Details |
C00637 | BRD-A25184723 | BRD-A25184723 | -- | -- | -- | Details |
C00638 | BRD-A25216804 | carbenoxolone | HSD11B1 | 11-beta-HSD1 inhibitor | -- | Details |
C00639 | BRD-A25234499 | aminoglutethimide | CYP11A1; CYP19A1 | Glucocorticoid receptor antagonist | -- | Details |
C00640 | BRD-A25243629 | BRD-A25243629 | -- | -- | -- | Details |
C00641 | BRD-A25337146 | AT-SUMO-1 | -- | -- | -- | Details |
C00642 | BRD-A25416824 | BRD-A25416824 | -- | -- | -- | Details |
C00643 | BRD-A25537246 | BRD-A25537246 | -- | -- | -- | Details |
C00644 | BRD-A25569250 | KI-16425 | LPAR1; LPAR3 | Lysophosphatidic acid receptor antagonist | -- | Details |
C00645 | BRD-A25576662 | streptozotocin | -- | -- | -- | Details |
C00646 | BRD-A25619068 | fadrozole | CYP19A1 | Aromatase inhibitor | -- | Details |
C00647 | BRD-A25687296 | emetine | RPS2 | Protein synthesis inhibitor | -- | Details |
C00648 | BRD-A25736793 | everolimus | MTOR | MTOR inhibitor | -- | Details |
C00649 | BRD-A25775766 | securinine | GABRA1 | TP53 activator; GABA receptor antagonist | -- | Details |
C00650 | BRD-A25829966 | BRD-A25829966 | -- | -- | -- | Details |
C00651 | BRD-A25852694 | BRD-A25852694 | -- | -- | -- | Details |
C00652 | BRD-A25852922 | ST-4034902 | -- | -- | -- | Details |
C00653 | BRD-A25869984 | BRD-A25869984 | -- | -- | -- | Details |
C00654 | BRD-A25883214 | BRD-A25883214 | -- | -- | -- | Details |
C00655 | BRD-A25993094 | BRD-A25993094 | -- | -- | -- | Details |
C00656 | BRD-A26002865 | verrucarin-a | -- | -- | -- | Details |
C00657 | BRD-A26030894 | BRD-A26030894 | -- | -- | -- | Details |
C00658 | BRD-A26032986 | zaldaride | CALM1 | Calmodulin antagonist | -- | Details |
C00659 | BRD-A26095496 | clobetasol | NR3C1 | Glucocorticoid receptor agonist | -- | Details |
C00660 | BRD-A26097136 | bulleyaconitine-a | -- | -- | -- | Details |
C00661 | BRD-A26112980 | salsolinol | -- | -- | -- | Details |
C00662 | BRD-A26165232 | BRD-A26165232 | -- | -- | -- | Details |
C00663 | BRD-A26199074 | calmidazolium | ATP2B1; PDE1A | Calmodulin antagonist; Calcium channel blocker | -- | Details |
C00664 | BRD-A26222320 | BRD-A26222320 | -- | -- | -- | Details |
C00665 | BRD-A26333730 | BRD-A26333730 | -- | -- | -- | Details |
C00666 | BRD-A26334849 | propafenone | KCNH2; SCN5A | Antiarrhythmic | -- | Details |
C00667 | BRD-A26343863 | BRD-A26343863 | -- | -- | -- | Details |
C00668 | BRD-A26347577 | BRD-A26347577 | -- | -- | -- | Details |
C00669 | BRD-A26384407 | chlortalidone | -- | -- | chlorthalidone | Details |
C00670 | BRD-A26423207 | sparfloxacin | -- | -- | -- | Details |
C00671 | BRD-A26503646 | formestane | CYP19A1 | Aromatase inhibitor | -- | Details |
C00672 | BRD-A26583774 | BRD-A26583774 | -- | -- | -- | Details |
C00673 | BRD-A26595446 | BRD-A26595446 | -- | -- | -- | Details |
C00674 | BRD-A26627799 | BRD-A26627799 | -- | -- | -- | Details |
C00675 | BRD-A26640795 | BRD-A26640795 | -- | -- | -- | Details |
C00676 | BRD-A26690767 | saquinavir | -- | -- | -- | Details |
C00677 | BRD-A26711594 | nicardipine | CACNA1C | Calcium channel blocker | -- | Details |
C00678 | BRD-A26777759 | VU-0447127-2 | -- | -- | -- | Details |
C00679 | BRD-A26787626 | cyclopiazonic-acid | ATP2A1 | ATPase inhibitor | -- | Details |
C00680 | BRD-A26845397 | isamoltane | HTR1A; HTR1B | Adrenergic receptor antagonist | -- | Details |
C00681 | BRD-A26952628 | BRD-A26952628 | -- | -- | -- | Details |
C00682 | BRD-A26962727 | BRD-A26962727 | -- | -- | -- | Details |
C00683 | BRD-A27056524 | BRD-A27056524 | -- | -- | -- | Details |
C00684 | BRD-A27080191 | BRD-A27080191 | -- | -- | -- | Details |
C00685 | BRD-A27143604 | dpn | -- | -- | diarylpropionitrile | Details |
C00686 | BRD-A27290375 | atropine | CHRM1; CHRM2; CHRM3; CHRM4; CHRM5 | Acetylcholine receptor antagonist | -- | Details |
C00687 | BRD-A27370296 | cyclandelate | -- | -- | -- | Details |
C00688 | BRD-A27376179 | lestaurtinib | FLT3; NTRK1 | JAK inhibitor; FLT3 inhibitor; Growth factor receptor inhibitor | -- | Details |
C00689 | BRD-A27407220 | BRD-A27407220 | -- | -- | -- | Details |
C00690 | BRD-A27422067 | BRD-A27422067 | -- | -- | -- | Details |
C00691 | BRD-A27489425 | rolitetracycline | -- | -- | -- | Details |
C00692 | BRD-A27554692 | altrenogest | PGR | Progestogen hormone | -- | Details |
C00693 | BRD-A27640568 | BRD-A27640568 | -- | -- | -- | Details |
C00694 | BRD-A27693633 | BRD-A27693633 | -- | -- | -- | Details |
C00695 | BRD-A27732521 | tolperisone | CYP2C19; CYP2D6 | Voltage-gated sodium channel blocker | -- | Details |
C00696 | BRD-A27844016 | BRD-A27844016 | -- | -- | -- | Details |
C00697 | BRD-A27887842 | prednisolone | -- | -- | -- | Details |
C00698 | BRD-A27924917 | BRD-A27924917 | -- | -- | 2-hydroxysaclofen | Details |
C00699 | BRD-A28019035 | etiocholanolone | -- | -- | -- | Details |
C00700 | BRD-A28095882 | zonisamide | SCN11A; SCN1A; SCN2A; SCN3A; SCN4A; SCN5A; SCN9A; CA1; CA7; CA12 | Sodium channel blocker; T-type calcium channel blocker | -- | Details |
C00701 | BRD-A28105619 | BRD-A28105619 | -- | -- | cucurbitacin-i | Details |
C00702 | BRD-A28153253 | BRD-A28153253 | -- | -- | -- | Details |
C00703 | BRD-A28219573 | BRD-A28219573 | -- | -- | -- | Details |